Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis.
The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS.
URMC rheumatologist presents data showing drug’s potential to ease arthritis symptoms
Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey.
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events.
Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons.
Physicians from Accentia and Johns Hopkins University present plans for new MS drug study for Cyrevia
Teva announces top-line results from GALA Phase III trial evaluating a new dosage for glatiramer acetate given three times weekly for relapsing-remitting multiple sclerosis
Genmab announces positive top-line Phase II results of ofatumumab in multiple sclerosis
Pregnancy outcomes in patients exposed to interferon beta-1b.
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.
Food and Drug Administration drug insert for Campath (alemtuzumab)
The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.
Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis (MIRROR)
Glatiramer acetate in the treatment of multiple sclerosis
Control of oxidative stress and inflammation in sickle cell disease with the Nrf2 activator dimethyl fumarate.
Rituximab for refractory digital infarcts and ulcers in systemic sclerosis.
Santhera Announces Successful Outcome of Phase III Study with Catena®/Raxone® in Duchenne Muscular Dystrophy
IgE-Mediated Allergic Reactions after the First Administration of Glatiramer Acetate in Patients with Multiple Sclerosis.
Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-β Therapy in Multiple Sclerosis.
Multiple sclerosis immunology: The healthy immune system vs the MS immune system.
Quality of life and depression in multiple sclerosis patients: longitudinal results of the BetaPlus study.
Natalizumab treatment during pregnancy - effects on the neonatal immune system.
Fingolimod Impedes Schwann Cell-Mediated Myelination: Implications for the Treatment of Immune Neuropathies?Effect of Fingolimod on Schwann Cells.
Nephrotic syndrome in multiple sclerosis patients who had undergone long-term interferon β-1b therapy.

Pages